GammaCoeur
Commercial- Indications
- Cardiovascular disease risk assessment
Company intelligence / Profile preview
Gamma Therapeutics
Portland, Oregon, United Statesgammadiagnostics.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Gamma Therapeutics develops protein-based diagnostics and therapeutics targeting cardiovascular disease risk, surgical therapy, and trauma care. Its lead product "GammaCoeur" CVD Risk Assay was in beta testing/pre-FDA review as of the last available updates. Other pipeline products include an anticoagulant blood thinner ("Gammarin"), a surgical sealant ("GammaSeal"), and a hemostatic dressing for trauma/military use ("GammaTF"). The company has received NIH/SBIR funding ($1.46M) to support its development efforts.
- Therapeutic areas
- OtherCardiovascular
- Modalities
- ProteinDiagnostic test/DeviceSurgical sealant/biologic deviceAnticoagulant blood thinner/protein therapeuticHemostatic dressing/device
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
ZEUS Scientific (manufacturing partner for ELISA immunoassay kits)
Beyond the preview
Go deeper on Gamma Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gamma Therapeutics.